hippuric acid has been researched along with butyrylcarnitine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Beaumont, M; Cassidy, A; Glastonbury, CA; Jackson, MA; Jennings, A; MacGregor, A; Martin, TC; Menni, C; Mohney, RP; Pallister, T; Small, KS; Spector, TD; Steves, CJ; Valdes, AM | 1 |
Akrami, M; Chamoto, K; Fagarasan, S; Hatae, R; Hirai, T; Honjo, T; Kawaguchi, S; Kim, YH; Masuda, I; Matsuda, F; Okuno, Y; Ozasa, H; Sakamori, Y; Sonomura, K; Taneishi, K; Yoshida, H | 1 |
2 other study(ies) available for hippuric acid and butyrylcarnitine
Article | Year |
---|---|
Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profiling.
Topics: Adult; Bilirubin; Biomarkers; Blood; Butyrates; Carnitine; Diet; Eating; Feces; Female; Fruit; Gastrointestinal Microbiome; Globins; Hippurates; Homeostasis; Humans; Indoles; Intra-Abdominal Fat; Male; Metabolomics; Nerve Tissue Proteins; Neuroglobin; Nutritional Status; Oxidation-Reduction; Red Meat; United Kingdom; Valerates; Vegetables; Yogurt | 2017 |
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carnitine; Drug Therapy, Combination; Energy Metabolism; Female; Glutathione Disulfide; Hippurates; Humans; Immunotherapy; Lung Neoplasms; Male; Microbiota; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Prospective Studies | 2020 |